ORTINLABSS

Ortin Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange about related Party Transactions

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange about related Party Transactions for the year ended 31.03.2020

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has submitted to the Exchange a copy of disclosures of related party transactions on a consolidated basis, pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, in the format specified in the relevant accounting standards for the year ended September 30, 2019.

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange regarding change in Registered Office of the company.

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015The trading window in respect of the Company s Securities shall remain closed for all the Directors/Officers/Designed Employees of the Company from the trading hours on 06.09.2017 till close of the trading hours on 16.09.2017 as per the code of Internal Procedure and Conduct for Prevention of Insider Trading adopted by the Company for declaration of un-audited financial results for the quarter ended 30.06.2017.

Ortin Laboratories Limited has informed the Exchange regarding Closure of Trading Window for the audited Financial results for the quarter and year ended March 31, 2017.

Ortin Laboratories Limited has informed the Exchange that the trading window in respect of the Company's securities shall remain closed for all the Directors/Officers/Designed Employees of the company from the trading hours on February 03, 2017 till close of the trading hours on February 16, 2017 as per the code of internal procedure and Conduct for prevention of Insider Trading adopted by the Company for declaration of un-audited financial results for the quarter ended December 31, 2016.

Ortin Laboratories Limited has informed the Exchange that the trading window in respect of the Company's Securities shall remain closed for all the Directors/Officers/Designed Employees of the Company from the trading hours on November 03, 2016 till close of the trading hours on November 14, 2016 as per the code of Internal Procedure and Conduct for Prevention of Insider Trading adopted by the Company for declaration of un audited financial results for the quarter and half year ended 30.09.2016.

Ortin Laboratories Limited has informed the Exchange that the trading window in respect of the Company's securities shall remain closed for all the Directors/Officers/Designed Employees of the company from the trading hours on August 25, 2016 till close of the trading hours on August 31, 2016 as per the code of internal procedure and Conduct for prevention of Insider Trading adopted by the Company for consideration of proposal of demerger of the business of the Company.

Ortin Laboratories Limited has informed the Exchange that Trading window closure from August 5, 2016 to August 16, 2016.

Ortin Laboratories Limited has informed the Exchange that the trading window in respect of the Company's Securities shall remain closed for all the Directors/Officers/Designed Employees of the Company from the trading hours on May 17, 2016 till close of the trading hours on June 01, 2016 as per the code of lnternal Procedure and Conduct for Prevention of lnsider Trading adopted by the Company fordeclaration of audited financial results for the quarter and year ended March 31, 2016. Trading window closure for consideration of audited financial results for the quarter and year ended March 31, 20

Ortin Laboratories Limited has informed the Exchange that as per the Company's internal Code for Prevention of Insider Trading (as amended w.e.f 15.05.2015) the trading window for dealing in the securities of the Company is closed for the Company's Directors / Officers and designated employees of the Company from February 01, 2016 and will re-open 48 hours after the publication of the December quarter end results to the public in the Board Meeting scheduled to be held on February 11, 2016.

Ortin Laboratories Limited has informed the Exchange that the trading window for dealing in the securities of the Company is closed for the Company's Directors / Officers and designated employees of the Company from November 04, 2015 and will re-open 48 hours after the publication of the September quarter results to the public in the Board Meeting scheduled to be held on November 14, 2015.